Sa. Priola et al., PRION PROTEIN AND THE SCRAPIE AGENT - IN-VITRO STUDIES IN INFECTED NEUROBLASTOMA-CELLS, Infectious agents and disease, 3(2-3), 1994, pp. 54-58
The mouse neuroblastoma cell line N2a was persistently infected with t
he Chandler strain of the mouse scrapie agent. Although the infection
did not spread to infect > 1% of the cells, clones were established th
at had from 50 to 100% infected cells. These clones expressed the abno
rmal protease-resistant form of prion protein (PrP), which is believed
to mediate brain degeneration in animals with scrapie and bovine spon
giform encephalopathy and in humans with kuru, Creutzfeldt-Jakob disea
se, and Gerstmann-Straussler-Scheinker syndrome. With this in vitro sy
stem, Congo red and several sulfated polysaccharides, including hepari
n and pentosan polysulfate, were found to inhibit accumulation of prot
ease-resistant PrP. These results and additional data confirming PrP b
inding to heparin suggested a possible role for sulfated glycosaminogl
ycans in the generation of protease-resistant PrP during scrapie infec
tion. Accumulation of protease-resistant PrP was also blocked in vitro
by expression of foreign PrP molecules, indicating that PrP from diff
erent species might compete for common substrates in this process. The
se results using scrapie infected cell lines provide new opportunities
for development of drugs capable of blocking the brain degeneration c
aused by scrapie and other transmissible spongiform encephalopathies.